HilleVax (NASDAQ:HLVX) Shares Up 6.2%

HilleVax, Inc. (NASDAQ:HLVX – Get Rating) shares were up 6.2% during trading on Friday . The stock traded as high as $16.62 and last traded at $16.62. 4 shares were traded during trading, a decline of 100% from the average session volume of 38,379 shares. The stock had previously closed at $15.65.

HilleVax Price Performance

The company has a debt-to-equity ratio of 0.02, a current ratio of 34.77 and a quick ratio of 34.77. The business’s 50-day moving average price is $16.63 and its two-hundred day moving average price is $16.26.

HilleVax (NASDAQ:HLVX – Get Rating) last released its earnings results on Thursday, November 10th. The company reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.88) by $0.43. On average, sell-side analysts anticipate that HilleVax, Inc. will post -6.93 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Strs Ohio acquired a new position in shares of HilleVax during the 2nd quarter worth $32,000. American International Group Inc. bought a new position in shares of HilleVax in the second quarter worth about $66,000. JPMorgan Chase & Co. acquired a new stake in shares of HilleVax in the 2nd quarter valued at approximately $76,000. Point72 Hong Kong Ltd bought a new stake in shares of HilleVax during the 2nd quarter valued at approximately $76,000. Finally, MetLife Investment Management LLC acquired a new position in HilleVax during the 3rd quarter worth approximately $137,000. 99.11% of the stock is currently owned by institutional investors and hedge funds.

HilleVax Company Profile

(Get Rating)

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.